Opponent Testimony on House Bill 291 — Susanna Whitman, Resident (House Development Committee)
Summary
Written opponent testimony on House Bill 291, Create the Ohio International Trade Commission, from Susanna Whitman, identified as a resident, to the House Development Committee, dated 6/17/2025. Whitman writes that the bill raises serious questions regarding transparency, accountability and public input. The testimony argues that Ohio's anti-Boycott, Divestment, and Sanctions law (ORC 9.76) could shield the Commission from democratic scrutiny and that Section G, which allows individuals, corporations and other organizations to fund the Commission, means private or foreign interests could direct public trade policy. It urges a no vote on House Bill 291.
Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used
Cite this document
“Opponent Testimony on House Bill 291 — Susanna Whitman, Resident (House Development Committee).”
Archived at Pandemic Darlings, https://pandemicdarlings.com/source-documents/2025-06-18-development-testimony-testimony-10484-ea97ca5332/
, SHA-256 d6f90be91af680248cb57c63164a64c66e348a964494f7173a25c171f62eb009.Full text
Opponent Testimony on House Bill 291 Create the Ohio International Trade Commission Susanna Whitman – Resident Before the House Development Committee 6/17/2025 Chairman Hoops, Vice Chairman Lorenz, Ranking Member Abdullahi, and esteemed members of the House Development Committee: Thank you for the opportunity to submit written testimony in opposition to House Bill 291. My name is Susanna Whitman, and I am writing to express my deep concern about the direction and implications of this proposed legislation. While framed as an economic development initiative, this bill raises serious questions regarding transparency, accountability, public input, and complicity in international human rights violations—specifically in relation to Israel. A trade commission with Israel would lock Ohio into partnership with a country that the International Court of Justice has found to be in violation of international law and leading human rights organizations accuse of genocide. Israel’s war on Gaza has led to the deaths of over 55,000 Palestinians and has repeatedly targeted hospitals, journalists, and humanitarian workers, devastating medical infrastructure and humanitarian conditions. Ohio’s anti-Boycott, Divestment, and Sanctions (BDS) law (ORC 9.76) dangerously compounds the risks of this partnership. It could shield the Commission from democratic scrutiny by labeling any future attempts to scale back the partnership as “discriminatory” or “antisemitic”. For example, Ohio Attorney General has previously threatened that county treasurers are in violation of the anti-BDS law if they do not reinvest in Israel Bonds. Once this commission is created, attempts to limit or change it could be met with similar statements. Meanwhile Israel’s credit rating has been downgraded multiple times and remains at risk of further decline under strain from its prolonged military campaign. This is not a sound economic partner—it is politically volatile and fiscally unstable. Section G allows “individuals, corporations, foundations, governmental agencies, and public and private organizations” to fund the Commission, meaning private or foreign interests could end up directing public trade policy. At a time when our state faces needs in healthcare, infrastructure, and education, HB 291 proposes diverting state resources toward international tech ventures with no guarantees of benefit to Ohio’s working families or small businesses, no clear metrics for success, no financial transparency, and no protections against donor influence. I urge you to vote no on House Bill 291. Thank you.
File and source
- File
- 2025-06-18_development_testimony_testimony-10484.pdf
- Size
- 83,304 bytes
- SHA-256
- d6f90be91af680248cb57c63164a64c66e348a964494f7173a25c171f62eb009
- Original
- No public link identified.